Navigation Links
Monoclonal Antibody Industry 2013 Global and China Market Analysis in New Research Report at RnRMarketResearch.com
Date:2/1/2013

aceutical are now marching into the monoclonal antibody market by huge capitals successively.

As of December 2012, the first monoclonal antibody generic drug (generic drug of enbrel) – Anbainuo® of Hisun Pharmaceutical was under phase III clinical supplementary test, and is expected to be approved by the end of 2013. The commercialized capacity will be 3.2 million pieces per year; furthermore, Enbrel has been tested in Brazil, etc., and is expected to achieve export.

In July 2012, the environmental impact assessment concerning phase I of new medicine pilot test base project (monoclonal antibody agents) of Fosun Pharmaceutical was publicized. According to the notice, the pilot scale of the project will be 130kg/a (equal to 1.3 million pcs/a of Rituximab), and the construction content involves raw material storage, pilot workshop, quality inspection, administration building and supporting public auxiliary facilities.

In April 2012, Walvax Biotechnology announced to jointly sign Cooperation Framework Agreement with Shanghai Fengmao Biotechnology, Shanghai Winlord Industries & Trading, and natural persons Wang Xiaofei and Kong Haiyan , planning to invest in Shanghai Fengmao in future four years, and research and industrialize Rituximab, Bevacizumab, Adalimumab, Panitumumab, Denosumab and long-acting EPO; in August, the company invested RMB246 million to establish the fully-owned subsidiary Shanghai Walvax, so as to promote the industrialization of the above six blockbuster bio-similar products. Nevertheless, according to the public information, the monoclonal antibody generic drugs of Walvax Biotechnology cannot be marketed until 2017 (Rituximab and Panitumumab as planned), and the commodity volume is expected to be 12kg/a, sharing 10% of planned capacity.

Comprehensive Table of Contents and more @

SOURCE RnRMarketResearch.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. VLST Corporation Announces In-licensing Agreement with Pfizer for Anti-CD40 Monoclonal Antibody
2. WuXi PharmaTech and Open Monoclonal Technology Announce OmniRat(TM) Antibody Collaboration
3. Synthetic Biologics Initiates Development of Monoclonal Antibodies for Treatment of Acinetobacter Infections
4. GenScript Anuncia Exposição Itinerante Junto com a Open Monoclonal Technology, Inc.
5. GenScript anuncia una muestra itinerante conjunta con Open Monoclonal Technology, Inc.
6. GenScript kündigt gemeinsame Roadshow mit Open Monoclonal Technology, Inc. an
7. GenScript anuncia un programa conjunto con Open Monoclonal Technology, Inc.
8. GenScript Announces Joint Road Show with Open Monoclonal Technology, Inc.
9. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
10. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
11. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ATLANTA , June 30, 2015 Legal-Bay ... the first bellwether trial in the multidistrict litigation (MDL) ... scheduled to begin October 13 th , 2015. There ... Inc. which have been consolidated before a federal judge ... that the first bellwether trial will begin in October ...
(Date:6/29/2015)... , June 29, 2015  Daktari Diagnostics was honored at ... Technology in the Service of Society Award. IEEE President and ... Barry L. Shoop presented the award to Principal Scientist ... ceremony was held Saturday, June 20, 2015, at the historic ... . "I have spent more than 3 ...
(Date:6/29/2015)... Minn. , June 29, 2015 EnteroMedics ... of devices that use neuroblocking technology to treat obesity, ... it has commenced an underwritten public offering of units. ... stock, Series A warrants to purchase common stock and ... purchase of units in the offering would result in ...
Breaking Medicine Technology:Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 2Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 3Daktari Honored with IEEE Spectrum Award 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3
... 5 P.M. EDT MONDAY, AUG. 4/, /ADVANCE/ ROCKVILLE, ... should not be,screened for prostate cancer, and younger men ... (PSA) test with their clinicians,before being tested, according to ... The recommendation and accompanying,evidence summary appear in the August ...
... 12 with 48-week boceprevir-based ... combination therapy ... KENILWORTH, N.J., Aug. 4 Schering-Plough,Corporation (NYSE: SGP ) today reported ... boceprevir, its investigational,oral hepatitis C protease inhibitor. The analysis showed a high ...
Cached Medicine Technology:Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer 2Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 2Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 4Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 5Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 6Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 7Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 8Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 9
(Date:6/30/2015)... ... ... Trenton Health Team has been certified by the New Jersey Department of Human ... serving the greater Trenton community. The ACO pilot is for a three-year period, ... structure of THT, bringing together the vast majority of Trenton’s primary and specialty care ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... Pharmacy’s premier event and tradeshow, taking place July 29 to August 1. Retail ... makers. , ThoughtSpot is a four-day event for independent community pharmacies, ...
(Date:6/30/2015)... ... 30, 2015 , ... The American Lung Association in California announced its new ... Diego. Speakers and clean air advocates included San Diego County Supervisor Ron Roberts, Dr. ... and Daniel Sullivan, founder and president of Sullivan Solar Power. , For every ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... titled, “University Post-Acute Rehab”. The video focuses on the rehab center’s patients and ... indicating it provides the best quality of services available. Each patient attests to ...
(Date:6/30/2015)... ... ... According to a June 15th report from USC News, a ... can be used to “decrease children’s anxiety and negative responses during oral care.” The ... patient experience in a “typical dental environment” with one that provides “visual, auditory and ...
Breaking Medicine News(10 mins):Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 3Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:Patients of University Post-Acute Rehab Support Five-Star Rating in New Video 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3
... June 6 (HealthDay News) -- Men who have type 2 ... from a regular exercise regimen, a new study has found. ... boost survival rates for men with both conditions, researchers found. ... which commonly occurs in people with diabetes and high blood ...
... A new poll by the Harvard School of Public Health ... the health care reform legislation enacted in 2006, 21% oppose ... heard or read about the law. The percentage of residents ... Support for the law varied by party affiliation, with 77% ...
... Hull have discovered a way to load up nanoparticles ... more effective form of photodynamic therapy (PDT) for treating ... light, cause irreparable damage to cells by creating toxic ... works with individual light-sensitive molecules but the new ...
... CHICAGO As the world marks the 30-year anniversary of ... a new challenge for people with the incurable disease. ... higher rate of cancers not usually associated with HIV. ... and neck, liver, kidney, and anal cancers, among others. ...
... A new targeted therapy for prostate cancer halts tumor ... resistant to hormone therapy, a new study finds. The ... 93rd Annual Meeting in Boston. "This targeted therapy ... lives of men with advanced, hormone-refractory prostate cancer," said ...
... Amanda Gardner HealthDay Reporter , SATURDAY, June 4 ... cancer drug, Avastin, may benefit both early stage ovarian cancer ... both studies, presented Saturday at the annual meeting of the ... added to standard chemotherapy. But the high cost ...
Cached Medicine News:Health News:Exercise Helps Men Battling Diabetes and Sleep Apnea 2Health News:Support for Massachusetts landmark health reform law rises in 2011 2Health News:Support for Massachusetts landmark health reform law rises in 2011 3Health News:Research creates nanoparticles perfectly formed to tackle cancer 2Health News:Many of those living with HIV face a new life-threatening challenge: cancer 2Health News:Many of those living with HIV face a new life-threatening challenge: cancer 3Health News:Targeted cancer therapy kills prostate tumor cells 2Health News:Cancer Drug Avastin Makes Inroads Against Ovarian Tumors 2Health News:Cancer Drug Avastin Makes Inroads Against Ovarian Tumors 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: